Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06805461 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06805461 · ClinicalTrials.gov record · last posted 2026-03-30

PumaRx Registry Trial

Study acronym: PumaRx
StatusRecruiting
PhaseNot specified
SponsorRenovoRx
Started2025-08-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath® device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath® catheter.

Amendment record 4 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 4 times since 2025-01-27; most recent amendment 2026-03-25. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-08-14
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT06805461
Lead Sponsor RenovoRx
Conditions Solid Tumors
Enrollment 1,000 participants
Start Date 2025-08-01
Primary Completion 2029-09-03 (estimated)
Study Completion 2029-09-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-30